Predicting polyglutamine diseases is now easier with a new AI model that uses machine learning. Researchers at Niigata University in Japan developed the model, and it showed a higher prediction accuracy than other methods. Read the study, published in Neurology Genetics, to learn more.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?